HomeProductsBioactive CompoundsProtein Kinase Targetsc-KitDasatinib Monohydrate
Chemical structure of CAS 863127-77-9

Dasatinib Monohydrate

CAS No.863127-77-9
MDL No.MFCD08704581
MFC22H28ClN7O3S
MW506.00
InChI KeyXHXFZZNHDVTMLI-UHFFFAOYSA-N

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
- -On RequestOn Request
Custom synthesis and bulk supply options are available upon request.

Product Information

Dasatinib monohydrate is the monohydrate form of dasatinib. It is used to treat chronic, accelerated, or myeloid/lymphoid blast phase chronic myeloid leukemia. The name 'dasatinib' refers to both the monohydrate (USAN) and anhydrous form (INN). It functions as an antineoplastic agent and tyrosine kinase inhibitor, containing anhydrous dasatinib.

CAS No.863127-77-9
Product NameDasatinib Monohydrate

Biological Targets

ABL1·BCR

Associated Conditions

Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive·B-cell acute lymphoblastic leukemia
* The information provided here is compiled from public sources and is for reference only.

Documentation

Similar Products